Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TUV Rheinland - a clarification:

This article was originally published in Clinica

Executive Summary

TUV Rheinland's application for notified body status under the In Vitro Diagnostics Directive (IVDD) will be made in collaboration with the UK Central Public Health Laboratory (CPHL) directly, rather than with the UK National Institute for Biological Standards and Controls (NIBSC) as reported in Clinica No 871, p 3. The NIBSC is not part of the CPHL. The NIBSC - a public health laboratory - is currently negotiating a contract with an unnamed third party testing and certification organisation to apply for notified body status under the IVDD.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel